Scarica l'app Stockscreener
10.68
0.47%
-0.05
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
8.65%
124.39
|
114.49 | 139.16 | 134.22 | 121.98 |
| Cost Of Revenue |
12.97%
38.12
|
33.74 | 50.35 | 58.60 | 54.76 |
| Gross Profit |
6.84%
86.28
|
80.75 | 88.82 | 75.63 | 67.23 |
Operating Expenses
|
50.53%
33.83
|
22.48 | 26.07 | 24.61 | 24.43 |
| Depreciation and Amortization |
3.15%
1.781
|
1.839 | 2.046 | 2.023 | 2.058 |
| Operating Income/Loss |
10.00%
52.45
|
58.27 | 62.75 | 51.01 | 42.80 |
| Nonoperating Income/Loss |
92.50%
-2.208
|
-1.147 | -1.156 | -3.497 | -2.701 |
| Income/Loss From Continuing Operations Before Tax |
12.06%
50.24
|
57.13 | 61.59 | 47.52 | 40.10 |
| Income Tax Expense/Benefit, Deferred |
99.91%
0.003
|
3.292 | 1.172 | 4.803 | 1.62 |
| Income Tax Expense/Benefit |
5.22%
12.41
|
11.80 | 12.22 | 11.09 | 5.878 |
|
Net Income/Loss
|
16.56%
37.82
|
45.33 | 49.38 | 36.43 | 34.22 |
| Basic Average Shares |
3.32%
228.23
|
236.07 | -0.109 | 238.60 | 241.49 |
| Diluted Average Shares |
4.01%
230.34
|
239.96 | -0.5867 | 244.66 | 248.61 |
| Basic Earnings Per Share |
10.53%
0.17
|
0.19 | 0.21 | 0.15 | 0.14 |
| Diluted Earnings Per Share |
15.79%
0.16
|
0.19 | 0.20 | 0.15 | 0.14 |
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):